Antenatal corticosteroids and outcomes in gastroschisis: A multicenter retrospective cohort study

In gastroschisis, there is evidence to suggest that gut dysfunction develops secondary to bowel inflammation; we aimed to evaluate the effect of maternal antenatal corticosteroids administered for obstetric reasons on time to full enteral feeds in a multicenter cohort study of gastroschisis infants.

[1]  Y. Ville,et al.  A randomised controlled trial of amnioexchange for fetal gastroschisis , 2019, BJOG : an international journal of obstetrics and gynaecology.

[2]  K. Baumstarck,et al.  Management and outcome challenges in newborns with gastroschisis: A 6-year retrospective French study , 2017, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[3]  R. Bergholz,et al.  Complex gastroschisis is a different entity to simple gastroschisis affecting morbidity and mortality-a systematic review and meta-analysis. , 2014, Journal of pediatric surgery.

[4]  M. Mogos,et al.  Perinatal Outcomes and Hospital Costs in Gastroschisis Based on Gestational Age at Delivery , 2014, Obstetrics and gynecology.

[5]  T. van Mieghem,et al.  Gastroschisis – what should be told to parents? , 2014, Prenatal diagnosis.

[6]  Shailesh Patel,et al.  Is early delivery beneficial in gastroschisis? , 2013, Journal of pediatric surgery.

[7]  A. Gafni,et al.  Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5). , 2013, JAMA pediatrics.

[8]  J. Kingdom,et al.  Expectant Management Compared With Elective Delivery at 37 Weeks for Gastroschisis , 2013, Obstetrics and gynecology.

[9]  E. Asztalos.  Antenatal Corticosteroids: A Risk Factor for the Development of Chronic Disease , 2012, Journal of nutrition and metabolism.

[10]  E. Draper,et al.  Gastroschisis: one year outcomes from national cohort study , 2011, BMJ : British Medical Journal.

[11]  M. Slim,et al.  Delivery of gastroschisis patients before 37 weeks of gestation is associated with increased morbidities. , 2009, Journal of pediatric surgery.

[12]  A. Gafni,et al.  Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial , 2008, The Lancet.

[13]  W. Jusko,et al.  Kinetics of Betamethasone and Fetal Cardiovascular Adverse Effects in Pregnant Sheep After Different Doses , 2006, Obstetrics and gynecology.

[14]  L. Sbragia,et al.  Impact of corticosteroid on intestinal injury in a gastroschisis rat model: morphometric analysis. , 2006, Journal of pediatric surgery.

[15]  W. Gilbert,et al.  Amniotic Fluid: Not Just Fetal Urine Anymore , 2005, Journal of Perinatology.

[16]  J. Tovar,et al.  Local dexamethasone improves the intestinal lesions of gastroschisis in chick embryos , 2004, Pediatric Surgery International.

[17]  R. Polin,et al.  Treatment and prevention of necrotizing enterocolitis , 2003, Seminars in Neonatology.

[18]  C. Rodeck,et al.  Intra‐amniotic inflammation in human gastroschisis: possible aetiology of postnatal bowel dysfunction , 1998, British journal of obstetrics and gynaecology.

[19]  E. Fonkalsrud,et al.  Effect of intraamniotic dexamethasone administration on intestinal absorption in a rabbit gastroschisis model. , 1995, Journal of pediatric surgery.

[20]  F. Morriss,et al.  Ontogenic development of gastrointestinal motility: IV. Duodenal contractions in preterm infants. , 1986, Pediatrics.

[21]  D. Tibboel,et al.  The natural history of gastroschisis during fetal life: development of the fibrous coating on the bowel loops. , 1986, Teratology.